» Articles » PMID: 10882856

Low Penetrance Genes Associated with Increased Risk for Breast Cancer

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2000 Jul 7
PMID 10882856
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Much effort in recent years has been focused on understanding the factors that contribute to breast cancer risk. Two major susceptibility alleles, BRCA1 and BRCA2, have been identified, and the prevalence and penetrance of mutations in these genes have been studied extensively. However, this work highlights the fact that only a small proportion of breast cancer is due to mutations in the genes. Evidence for additional high penetrance genes exists, but it is becoming clear that an understanding of multiple lower penetrance alleles will be necessary to fully define breast cancer risk. Work in this area has focused on the analysis of polymorphisms of potential functional significance in several classes of genes, including those involved in carcinogen metabolism, oestrogen metabolite biosynthesis, steroid hormone receptor activation and DNA damage response. These studies are reviewed and a strategy to use modification of breast cancer penetrance in families with known mutations in BRCA1 as a means of identifying additional low penetrance, or modifier, genes is discussed.

Citing Articles

Optimisation Models for Pathway Activity Inference in Cancer.

Chen Y, Liu S, Papageorgiou L, Theofilatos K, Tsoka S Cancers (Basel). 2023; 15(6).

PMID: 36980673 PMC: 10046797. DOI: 10.3390/cancers15061787.


Genetic Epidemiology of Breast Cancer in Latin America.

Zavala V, Serrano-Gomez S, Dutil J, Fejerman L Genes (Basel). 2019; 10(2).

PMID: 30781715 PMC: 6410045. DOI: 10.3390/genes10020153.


Genetic diversity, inbreeding and cancer.

Ujvari B, Klaassen M, Raven N, Russell T, Vittecoq M, Hamede R Proc Biol Sci. 2018; 285(1875).

PMID: 29563261 PMC: 5897632. DOI: 10.1098/rspb.2017.2589.


XRCC1 and OGG1 Gene Polymorphisms and Breast Cancer: A Systematic Review of Literature.

Moghaddam A, Nazarzadeh M, Noroozi R, Darvish H, Mosavi Jarrahi A Iran J Cancer Prev. 2016; 9(1):e3467.

PMID: 27366307 PMC: 4922200. DOI: 10.17795/ijcp-3467.


Genetic dissection of the Mom5 modifier locus and evaluation of Mom5 candidate genes.

Otterpohl K, Gould K Mamm Genome. 2015; 26(5-6):235-47.

PMID: 25976411 DOI: 10.1007/s00335-015-9567-x.